ABOS logo

Acumen Pharmaceuticals (ABOS) Free Cash Flow

Annual FCF

-$43.09 M
-$7.77 M-22.01%

31 December 2023

ABOS Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$24.60 M
-$8.05 M-48.62%

30 September 2024

ABOS Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$67.34 M
-$11.68 M-20.99%

30 September 2024

ABOS TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABOS Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.0%-90.5%-46.4%
3 y3 years-478.3%-219.6%-291.7%
5 y5 years---

ABOS Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-478.3%at low-571.1%at low-291.7%at low
5 y5 years-531.9%at low-1817.1%at low-3608.4%at low
alltimeall time-531.9%at low-1817.1%at low-3608.4%at low

Acumen Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$24.60 M(+48.6%)
-$67.34 M(+21.0%)
June 2024
-
-$16.55 M(-7.4%)
-$55.66 M(+9.6%)
Mar 2024
-
-$17.87 M(+114.6%)
-$50.78 M(+17.9%)
Dec 2023
-$43.09 M(+22.0%)
-$8.33 M(-35.5%)
-$43.09 M(-6.3%)
Sept 2023
-
-$12.91 M(+10.6%)
-$45.99 M(+8.6%)
June 2023
-
-$11.67 M(+14.7%)
-$42.35 M(+13.9%)
Mar 2023
-
-$10.18 M(-9.5%)
-$37.18 M(+5.3%)
Dec 2022
-$35.31 M
-$11.24 M(+21.3%)
-$35.31 M(+27.3%)
Sept 2022
-
-$9.26 M(+42.4%)
-$27.74 M(+6.0%)
June 2022
-
-$6.50 M(-21.7%)
-$26.17 M(+9.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$8.31 M(+126.7%)
-$23.94 M(+33.0%)
Dec 2021
-$18.00 M(+141.6%)
-$3.67 M(-52.4%)
-$18.00 M(+4.7%)
Sept 2021
-
-$7.70 M(+80.2%)
-$17.19 M(+59.5%)
June 2021
-
-$4.27 M(+80.2%)
-$10.78 M(+34.7%)
Mar 2021
-
-$2.37 M(-17.0%)
-$8.00 M(+7.4%)
Dec 2020
-$7.45 M(+9.3%)
-
-
Dec 2020
-
-$2.86 M(+122.7%)
-$7.45 M(+62.2%)
Sept 2020
-
-$1.28 M(-14.1%)
-$4.59 M(+38.8%)
June 2020
-
-$1.49 M(-17.7%)
-$3.31 M(+82.3%)
Mar 2020
-
-$1.82 M
-$1.82 M
Dec 2019
-$6.82 M
-
-

FAQ

  • What is Acumen Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals annual FCF year-on-year change?
  • What is Acumen Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals quarterly FCF year-on-year change?
  • What is Acumen Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals TTM FCF year-on-year change?

What is Acumen Pharmaceuticals annual free cash flow?

The current annual FCF of ABOS is -$43.09 M

What is the all time high annual FCF for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high annual free cash flow is -$6.82 M

What is Acumen Pharmaceuticals annual FCF year-on-year change?

Over the past year, ABOS annual free cash flow has changed by -$7.77 M (-22.01%)

What is Acumen Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of ABOS is -$24.60 M

What is the all time high quarterly FCF for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high quarterly free cash flow is -$1.28 M

What is Acumen Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, ABOS quarterly free cash flow has changed by -$11.68 M (-90.49%)

What is Acumen Pharmaceuticals TTM free cash flow?

The current TTM FCF of ABOS is -$67.34 M

What is the all time high TTM FCF for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high TTM free cash flow is -$1.82 M

What is Acumen Pharmaceuticals TTM FCF year-on-year change?

Over the past year, ABOS TTM free cash flow has changed by -$21.35 M (-46.42%)